Molecular and cellular signatures differentiate Parkinson’s disease from Parkinson’s disease with dementia
Aine Fairbrother-Browne(European Bioinformatics Institute), Mina Ryten(Guy's Hospital), Theodoros Xenakis(Great Ormond Street Hospital), Hemanth R. Nelvagal(Neurosciences Institute), Jonathan Brenton(Great Ormond Street Hospital), John Hardy(UK Dementia Research Institute), Regina H. Reynolds(Great Ormond Street Hospital), Yau Mun Lim(Queen Mary University of London), James R. Evans(The Francis Crick Institute), Kylie Montgomery(New England Biolabs (United States)), Melissa Grant‐Peters(Great Ormond Street Hospital), Zane Jaunmuktane(King's College London), Nicholas Wood(National Hospital for Neurology and Neurosurgery), Hannah Macpherson(University College London), Emil K. Gustavsson(University of British Columbia), Huw R. Morris(University College London), Henry Houlden(Queen Mary University of London), Toby J Curless(Neurosciences Institute), Sonia Gandhi(The Francis Crick Institute), Raquel Real(Neurosciences Institute), Nancy Chiraki(Neurosciences Institute), Amy R. Hicks(National Hospital for Neurology and Neurosurgery)
Cited by 4
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k